<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02819544</url>
  </required_header>
  <id_info>
    <org_study_id>PI2015_843_0020</org_study_id>
    <nct_id>NCT02819544</nct_id>
  </id_info>
  <brief_title>Evaluation of the Interest of the Instillation of Saline Intraperitoneally (INSI ) Versus Instillation of Naropin the Surgical Site Versus Lung Recruitment Maneuvers ( PVM ) in the Management of Pain After Laparoscopic Cholecystectomy in Ambulatory Care</brief_title>
  <acronym>VSD</acronym>
  <official_title>Prospective, Two-center , Randomized, ITT , Parallel Group Evaluating the Interest of the Instillation of Saline Intraperitoneally (INSI ) Versus Instillation of Naropin the Surgical Site Versus Lung Recruitment Maneuvers ( PVM ) in the Management of Pain After Laparoscopic Cholecystectomy in Ambulatory Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Known to reduce analgesics and length of hospitalization in conventional surgery, laparoscopy
      is characterized by frequent post-operative pain and can decrease the patient's quality of
      immediate postoperative life and sometimes the results of decision ambulatory care.

      In order to reduce these postoperative pain, various methods have been evaluated in numerous
      studies to determine their analgesic role.

      As part of abdominal surgery, local anesthetics (Naropin (Ropivacaine)) are generally
      administered in the end of surgery to reduce postoperative pain and promote recovery of the
      patient. In addition, it is also possible to instill the anesthetic directly into the
      abdominal cavity reducing pain transmitted by nociceptor viscera.

      In recent years, new methods have been proposed such as lung recruitment maneuvers and the
      instillation of saline solution to reduce postoperative pain.

      However, no recommendation is on the use of intraperitoneal saline under the management of
      postoperative pain after laparoscopic cholecystectomy in ambulatory care.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain measured by visual analog scale (VAS)</measure>
    <time_frame>between first postoperative day and 6th postoperative day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>global pain measured by BPI (Brief Pain Inventory) scale</measure>
    <time_frame>30th postoperative day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>analgesics use</measure>
    <time_frame>30th postoperative day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>global morbidity</measure>
    <time_frame>30th postoperative day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>specific complications for each treatment</measure>
    <time_frame>30th postoperative day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Surgery</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ropivacaine 7.5 mg/mL administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium chloride</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>NaCl 0.9% administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium chloride administration</intervention_name>
    <description>Sodium chloride administration</description>
    <arm_group_label>Sodium chloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine administration</intervention_name>
    <description>Ropivacaine administration</description>
    <arm_group_label>Ropivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged 18 to 80 years

          -  Patients with biliary pathology requiring cholecystectomy

          -  Patients with signed consent

          -  Patient eligible to outpatient care

          -  No allergy to Naropin

          -  Support by laparoscopy

          -  Patients affiliated to a social security s

        Exclusion Criteria:

          -  Contraindications for laparoscopy

          -  Contraindications to outpatient surgery

          -  Patients with an allergy to paracetamol or tramadol

          -  Patient with an addiction to painkillers and / or alcohol

          -  Patient with a disease causing chronic pain

          -  Patient using analgesics bearing 1 , 2 or 3 chronically

          -  Pregnant or breastfeeding women , of reproductive age without effective contraception

          -  Minor Patient,

          -  Contraindication to surgery,

          -  Physical or psychological state does not allow the patient's participation in the
             study ,
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Marc REGIMBEAU, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Marc REGIMBEAU, MD, PhD</last_name>
    <phone>+33 3 08 88 97</phone>
    <email>regimbeau.jean-marc@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Marc REGIMBEAU, MD, PhD</last_name>
      <phone>+33 3 22 08 88 97</phone>
      <email>regimbeau.jean-marc@chu-amiens.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Beauvais</name>
      <address>
        <city>Beauvais</city>
        <zip>60000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fran√ßois MAUVAIS, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2016</study_first_submitted>
  <study_first_submitted_qc>June 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2016</study_first_posted>
  <last_update_submitted>July 28, 2016</last_update_submitted>
  <last_update_submitted_qc>July 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Digestive System</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

